All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, March 6, 2021
Home » Topics » Science

Science
%{topic} RSS Feed RSS

Australian researchers create kidney tissue from iPS cells

Nov. 25, 2019
By Tamra Sami
No Comments
MELBOURNE, Australia – Researchers at the Murdoch Children’s Research Institute in Melbourne are pushing the boundaries on creating kidney tissue from stem cells.
Read More

Bioworld MedTech’s Cardiology Extra

Nov. 25, 2019
By Liz Hollis
No Comments
Keeping you up to date on recent developments in cardiology.
Read More
Test tube, dropper, DNA illustration

Bench Press for Nov. 22, 2019

Nov. 22, 2019
By Anette Breindl
No Comments
BioWorld looks at translational medicine.
Read More

Bioworld MedTech’s Neurology extra

Nov. 22, 2019
By Andrea Applegate and Anette Breindl
No Comments
Keeping you up to date on recent developments in neurology.
Read More

Bioworld MedTech’s Diagnostics extra

Nov. 21, 2019
By Meg Bryant and Anette Breindl
No Comments
Keeping you up to date on recent developments in diagnostics.
Read More

BioWorld MedTech's Orthopedics Extra

Nov. 20, 2019
By Holland Johnson
No Comments
Keeping you up to date on recent developments in orthopedics.
Read More
Older person holding cane

Double-duty CD4+ T cells may hold key to longevity

Nov. 19, 2019
By John Fox
No Comments
Researchers at the RIKEN Center for Integrative Medical Science (IMS) and Keio University School of Medicine (KUSM) in Japan have discovered that people ages 110 or longer, the so-called supercentenarians, have elevated blood levels of CD4+ cytotoxic T lymphocytes (CTLs).
Read More

BioWorld MedTech's Oncology Extra

Nov. 19, 2019
By Mark McCarty
No Comments
Keeping you up to date on recent developments in oncology.
Read More

WSU researchers weaponize nanoparticles to combat inflammatory diseases

Nov. 19, 2019
By Annette Boyle
No Comments
A team led by researchers at Washington State University (WSU) has developed a nanoparticle technology to deliver cell-killing drugs to shut down the overactive immune response that can cause damage or death in diseases like stroke and sepsis without affecting other cell types or compromising the immune system.
Read More

WSU researchers weaponize nanoparticles to combat inflammatory diseases

Nov. 19, 2019
By Annette Boyle
No Comments
A team led by researchers at Washington State University (WSU) has developed a nanoparticle technology to deliver cell-killing drugs to shut down the overactive immune response that can cause damage or death in diseases like stroke and sepsis without affecting other cell types or compromising the immune system.  
Read More
Previous 1 2 … 72 73 74 75 76 77 78 79 80 … 86 87 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 5.
  • Gloved hand places sample tubes in PCR system

    COVID-19 test makers are adapting for variants

    BioWorld MedTech
    As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for March 5.
  • Celltrion-Regkirona-2-9

    Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona

    BioWorld
    HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing